01 دی 1403
محمدجواد جهانشاهي

محمدجواد جهانشاهی

مرتبه علمی: استادیار
نشانی: جیرفت، کیلومتر 8 جاده بندرعباس، دانشگاه جیرفت. کد پستی: 78671-61167
تحصیلات: دکترای تخصصی / شیمی کاربردی
تلفن: +989103060069
دانشکده: دانشکده علوم پایه

مشخصات پژوهش

عنوان
Enhancing volumetric muscle loss (VML) recovery in a rat model using super durable hydrogels derived from bacteria
نوع پژوهش مقاله چاپ شده
کلیدواژه‌ها
ثبت نشده‌است!
پژوهشگران سید وحید نیک نژاد، مهدی مهرعلی، فریناز ریاحی خوراسگانی، رضا حیدری، فیروز بابو کوماندی، نسیم گل افشان، میگوئل کاستیلیو، کریستین پابلو پنیسی، مسعود حسنی، محمدجواد جهانشاهی، محمد مهرعلی، یونس قاسمی، نگار آذرپیرا، توماس ال اندرسن، علیرضا دولتشاهی پیروز

چکیده

Bacteria can be programmed to deliver natural materials with defined biological and mechanical properties for controlling cell growth and differentiation. Here, we present an elastic, resilient and bioactive polysaccharide derived from the extracellular matrix of Pantoea sp. BCCS 001. Specifically, it was methacrylated to generate a new photo crosslinkable hydrogel that we coined Pantoan Methacrylate or put simply PAMA. We have used it for the first time as a tissue engineering hydrogel to treat VML injuries in rats. The crosslinked PAMA hydrogel was super elastic with a recovery nearing 100 %, while mimicking the mechanical stiffness of native muscle. After inclusion of thiolated gelatin via a Michaelis reaction with acrylate groups on PAMA we could also guide muscle progenitor cells into fused and aligned tubes – something reminiscent of mature muscle cells. These results were complemented by sarcomeric alpha-actinin immunostaining studies. Importantly, the implanted hydrogels exhibited almost 2-fold more muscle formation and 50 % less fibrous tissue formation compared to untreated rat groups. In vivo inflammation and toxicity assays likewise gave rise to positive results confirming the biocompatibility of this new biomaterial system. Overall, our results demonstrate that programmable polysaccharides derived from bacteria can be used to further advance the field of tissue engineering. In greater detail, they could in the foreseeable future be used in practical therapies against VML.